Status:

ACTIVE_NOT_RECRUITING

No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography

Lead Sponsor:

Seoul National University Hospital

Collaborating Sponsors:

National Evidence-Based Healthcare Collaborating Agency

Conditions:

Breast Cancer

Sentinel Lymph Node

Eligibility:

FEMALE

19+ years

Phase:

NA

Brief Summary

NAUTILUS study is a prospective, multicenter, RCT. Clinically T1,T2, node negative BCS candidates with no evidence of metastases in AUS are 1:1 randomized into no SLNB group and SLNB group. NAUTILUS ...

Detailed Description

\[Background\] Skipping ALND, the follow-up treatment in SN-positive patients, has non-inferior oncological outcomes compared to SLNB-only group, given that there is no severe SN metastases. Axillary...

Eligibility Criteria

Inclusion

  • Women ≥ 19 years
  • Invasive unilateral breast carcinoma with histological confirmation
  • History of invasive breast cancer
  • Histologically or radiologically no suspicion of distant metastases
  • Performance status corresponding to ECOG grade 0-2
  • Tumor size clinically and radiologically ≤ 5cm, independent of hormone receptor and HER2 status
  • Clinically and sonographically negative axillary lymph nodes before biopsy; core needle biopsy or fine needle aspiration of suspicious lymph node required
  • BCS candidate with postoperative whole-breast irradiation and adequate systemic therapy
  • No psychological and geographical restriction in follow-up
  • Written informed consent

Exclusion

  • History of any cancer in the previous 5 years
  • Bilateral breast cancer
  • Invasive breast cancer treated with neoadjuvant therapy
  • Tumor size clinically and radiologically \> 5cm
  • Mastectomy candidate
  • Pregnancy and breastfeeding
  • Male breast cancer
  • Unable to understand and fill out questionnaires

Key Trial Info

Start Date :

September 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2027

Estimated Enrollment :

1734 Patients enrolled

Trial Details

Trial ID

NCT04303715

Start Date

September 15 2020

End Date

December 31 2027

Last Update

December 4 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea, 03080